Ø Quarterly Publication
Ø Abstracts also published in French language
Ø Fast Peer Review Process
Ø Manuscript Plagiarism Assessment
Ø Respectable Editorial Board
1. Name of Journal:
Research Journal of Health Sciences (RJHS). The Research Journal of Health Sciences is published quarterly (March, June, September and December).
2. Authorship
With regard to authorship guidelines, the RJHS subscribes to the recommendations of the International Committee of Medical Journal Editors (ICMJE). Guidelines based on those of the ICMJE are as follows: All persons designated as authors should qualify for authorship, and all those who qualify should be listed. Each author should have participated sufficiently in the work to take responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article.
Authorship credit should be based on
1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
2) drafting the article or revising it critically for important intellectual content; and
3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data, or general supervision of the research group, by themselves, do not justify authorship.
In the case of publications arising from research conducted by students, and where the student has done the majority of the work, the student will normally be the first author. Second authorship is appropriate for the supervisor provided the conditions outlined in the preceding paragraph are met. Second authorship is not acceptable if the supervisor only provides encouragement, physical facilities, financial support, critiques or editorial contributions.
Authors should be able to provide a description of what each contributed. All others who contributed to the work who are not authors should be included in the “Acknowledgements section”, and what they did should be described.
Authorship of multi-centre studies is attributed to a group. All members of the group who are named as authors should meet the authorship criteria listed above. Group members who do not meet these criteria should be listed, with their permission in the “Acknowledgements section”.
The order of authorship should be a joint decision of the co-authors. Authors should be prepared to explain the order in which authors are listed.
3. Article arrangement and style.
The text file should be arranged as enumerated below:
Title Page
The title page should contain:
· the full title (bold, lower case, font size 12, Times New Roman), ≤ 20 words
· details of each author: last name and initials, degrees, and affiliation
· corresponding author's e-mail address
· proposed running title
Abstract
· an abstract of 150 words which should summarize the objective(s), methodology, major findings and conclusions
· three to six keywords
Others
· the next pages should contain the text file divided into: Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Tables and Figures.
4. Conflict of Interest and Acknowledgments
Authors are required to disclose any potential conflict of interest. Acknowledgments should list brief statements of assistance, financial support, and prior publication of the study in abstract form, if applicable.
5. Copyright
By submitting manuscripts to RJHS authors of original articles are assigning copyright to the College of Health Sciences, Osun State University. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in RJHS for educational and research purposes without obtaining permission.
6. Ethics
Papers based on original research must adhere to the Declaration of Helsinki on "Ethical Principles for Medical Research Involving Human Subjects", and must specify from which recognized ethics committee approval for the research was obtained. Authors must indicate ethical conformity with the Helsinki Declaration 1975 (as amended). The institution’s Ethics Committee must have approved studies on human subjects. Informed consent of human subjects must be clearly stated in the manuscript. Animal experiments must be in conformity with international norms guided by relevant laws and the guidelines of the Institutional Animal Care and Use Committee (IACUC). The intent to publish in this journal must be supported by all authors and the manuscripts must not have been previously published or being considered for publication by any other journal. The use of trade names is unacceptable for medicinal products.
7. Manuscript Submission process
It is the policy of the RJHS that authors must conform to standards of good scientific practice and responsible authorship. Authors must accept responsibility for the entire contents of the submitted manuscript, and provide their significant contributions to the work. Submission of a manuscript implies that the work described has not been published previously; that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities at the institution(s) where the work has been carried out. All statements and opinions expressed in the manuscripts and published in the journal are strictly those of the author(s) and not necessarily those of the Editor(s) or Publisher. The Publisher disclaims any responsibility or liability for such materials. In addition, the Publisher is not liable and do not provide guarantee or endorsement for services or products advertised. The appearance of such advertisements in this journal does not constitute a guarantee or endorsement by the editorial board or the College of Health Sciences, of quality or value of any advertised product or service, or the claims made for them by advertisers.
Abstracts of Accepted manuscripts shall be published in French language. Finally, in a bid to reach a wider audience as well as relevant stakeholders, summaries of all publications shall be made available in simplified version on our webpage (www.rjhs.uniosun.edu.ng). All manuscripts must be submitted in Microsoft Word format preferably electronically as e–mail attachments.
All manuscripts for the RJHS should be submitted directly to:
The Editor, Research Journal of Health Sciences, Editorial Office, College of Health Sciences, Osun State University, Osogbo, Nigeria
E-mail: editor.rjhs@uniosun.edu.ng
8. Formatting guidelines:
The word processing program should be Microsoft Word. The text should be typed using the font Times New Roman, size 12 points, and organized on A4 format (21 x 29.5 cm). Italicize common and standard Latin words, abbreviations or phrases such as «et al.», «e.g.» or «in vivo». Italicize the names of genes (e.g. Arpl gene), genera and species.
Tables
Tables must be placed on a separate page, below the list of references. All tables are to be numbered using Arabic numerals. Tables should always be cited in the text in consecutive numerical order. For each table, authors must supply a table caption (title) explaining the components of the table. Footnotes to tables must be placed below the body of the table and should be indicated with superscript lowercase letters. Ensure that the data presented in tables do not duplicate results described elsewhere in the article.
Figures
Figures must be placed in a separate section below tables. Ensure that each figure has a caption. Supply captions in a separate section (not attached to the figure) below the figures. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum however and explain all symbols and abbreviations used.
Colored figures will appear in color on the web regardless of whether or not these illustrations are reproduced in color in the printed version. The author(s) will bear the extra costs involved in producing printed colored figures, if required. For color reproduction in print, author(s) will receive information regarding the costs after manuscripts have been accepted for publication.
Original Articles
Original Articles should be clinical or basic studies. Translational research that adds new information to the aetiology, treatment, and outcomes of health conditions that have not been published previously will be given accelerated editorial processing. Each manuscript should not exceed 3,000 words (excluding tables, figures and references), and not more than 30 references. Not more than 8 figures/tables (in total) are acceptable. Cover letter, title page and abstract are required.
Case Reports/Case Series
Case reports should consist of unusual case(s) and a brief review of the literature pertaining to these case(s) that add new information to the health knowledge. These case reports should not exceed 1,500 words, 15 references, and 4 figures/tables in all. Cover letter, title page and abstract are required.
Review Articles
All submitted review articles shall be subjected to the same peer-review and editorial processes as Original Articles. The Journal shall not publish not more than one review article per edition except the Editorial team decides otherwise. The text of Review Articles must be limited to 3,500 words, with a maximum of 6 figures and tables (total) and up to 60 references. Cover letter, title page and abstract are required.
Referencing in the text
1. References must conform to Vancouver style. Journal title should conform to the abbreviation in index medicus. Journal articles should be cited in this format: Author’s name and initials, title of article, abbreviated name of journal, year of publication, volume (issue) and pages.
2. Books: Mbagwu SM. A pictorial self-instruction manual on skin diseases, Lagos: Longman, 2012.
3. Chapters in Books: Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein OJ, editors. Infectious disease of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders Co, 1994; p. 141-267.
4. In-text citation is with standard numbers in brackets, e.g., (1,2). Authors are responsible for completeness and accuracy of all citations. A maximum of six authors should be quoted followed by et al. In the list of references, all references in the text are numbered consecutively in the order they appear in the text.
9 Review Process
Peer review process will be in relation to scientific and statistical contents. Three referees, active in the relevant field of the submitted manuscript, will review manuscripts submitted for publication. Reviewers are knowledgeable of the research area and will not have a conflict of interest. Only papers with favorable reports will be accepted for publication. The Editorial Board shall decide the acceptance of manuscripts for publication. When the article is published the corresponding author will be able to download freely the electronic reprint of the article in Adobe’s PDF format from the Journal website.
10. Contact Information
Please ensure that contact information such as e-mail addresses and fax numbers, for all authors are current to facilitate follow-up regarding manuscripts. The Editor should be promptly notified of any changes in such information.
11. General Information
The Journal is institutional based (www.uniosun.edu.ng), with the editorial office at the College of Health Sciences, Osun State University, Osogbo. The Editorial Team from the outset ensure that the Journal is standardized and indexed appropriately. All manuscripts will always be reviewed by at least three peer reviewers, and by our language / reference / formatting editors. We also subject all accepted manuscripts to plagiarism software to assess manuscripts for plagiarism. All accepted abstracts would be translated into French language so as to reach the Francophone readers. Our goal is to make Research Journal an outstanding health sciences journal within the sub-Saharan Africa.
One of the unique characteristics of the Journal website is to have a section where we can display summary of research works in a language that the general population including stakeholders and policy makers can understand. All authors of accepted manuscripts shall be required to submit a 500 word summary (in simple language) structured as follows:
Title:
Manuscript Number:
Background:
Why Was This Study Done?
What Did the Researchers Do and Find? Provide Top 10 references:
The summary shall be translated without any charges to the Authors.
12. Submission Checklist
- Indicate type of article on title page (e.g. Original Article, Case Report, Review Article, etc)
- Provide complete names, degrees, and contacts / affiliations for all authors
- Designate a corresponding author, with complete mailing and e-mail addresses and telephone
- Provide a structured abstract of 150 words and 3-6 key words for subject indexing
- Cite references, figures, and tables in recommended formats
- Check all references for completeness and accuracy
- Submit each table / figure on a separate page
- Clearly number figures and indicate orientation. Submit each figure on a separate page
- Identify and provide permission for reuse of any previously published material
- Disclose any potential conflict of interest
13. Processing & Publication charges
a) It has become imperative for RJHS to charge a processing fee of $30 dollars or its equivalent, upon submission of manuscripts. This is to handle editorial activities including plagiarism assessment and translation of abstracts to the French language.
b) Once manuscripts are ACCEPTED for publication, authors are required to immediately pay a non-refundable publication fee of $100 or its equivalent. This is to print hard copies of the journal regularly. The journal does not have any other source of income other than processing and publication charges from authors.
c) However as stated under Formatting Guidelines (under Figures), author(s) will
bear the extra cost involved in producing printed colored figures, if required. For color reproduction in print, author(s) will receive information regarding the costs after manuscripts have been accepted for publication.
d) Fees charged are subject to review as may be dictated by inflation and overhead running costs.
PROCESSING FEE
$30 = N13,845
Please pay into this Naira account: First Bank, College of Health Sciences. Current Account: 2010503894
PLEASE ENSURE THAT YOU STATE CLEARLY ‘RJHS Processing Fee’ in the narration when making payment.
Kindly inform us immediately when payment is made and scan the teller to us. All payments shall be acknowledged through the dedicated editorial email address.
PUBLICATION FEE
$100 = N46,150
Please pay into this Naira account: First Bank, College of Health Sciences. Current Account: 2010503894
PLEASE ENSURE THAT YOU STATE CLEARLY ‘RJHS Publication Fee’ in the narration when making payment.
Kindly inform us immediately when payment is made and scan the teller to us. All payments shall be acknowledged through the dedicated editorial email address.
Copyright Notice
By submitting manuscripts to RJHS authors of original articles are assigning copyright to the College of Health Sciences, Osun State University. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in RJHS for educational and research purposes without obtaining permission.
CREATIVE COMMONS ATTRIBUTION-NONCOMMERCIAL-NODERIVATIVES 4.0 INTERNATIONAL PUBLIC LICENSE By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions. Section 1 – Definitions. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license. Licensor means the individual(s) or entity(ies) granting rights under this Public License. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning. Section 2 – Scope. License grant. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to: reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and produce and reproduce, but not Share, Adapted Material for NonCommercial purposes only. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions. Term. The term of this Public License is specified in Section 6(a). Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material. Downstream recipients. Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i). Other rights. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise. Patent and trademark rights are not licensed under this Public License. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes. Section 3 – License Conditions. Your exercise of the Licensed Rights is expressly made subject to the following conditions. Attribution. If You Share the Licensed Material, You must: retain the following if it is supplied by the Licensor with the Licensed Material: identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated); a copyright notice; a notice that refers to this Public License; a notice that refers to the disclaimer of warranties; a URI or hyperlink to the Licensed Material to the extent reasonably practicable; indicate if You modified the Licensed Material and retain an indication of any previous modifications; and indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License. For the avoidance of doubt, You do not have permission under this Public License to Share Adapted Material. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable. Section 4 – Sui Generis Database Rights. Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material: for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only and provided You do not Share Adapted Material; if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database. For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights. Section 5 – Disclaimer of Warranties and Limitation of Liability. Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You. To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability. Section 6 – Term and Termination. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates: automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or upon express reinstatement by the Licensor. For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License. Sections 1, 5, 6, 7, and 8 survive termination of this Public License. Section 7 – Other Terms and Conditions. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License. Section 8 – Interpretation. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.
